Role: Conception, Design
3-folded brochure to educate public about research project developed by Dr. Henry Klassen and his team. In late 2012, team led by Dr. Klassen was granted by California Institute for Regenerative Medicine (CIRM) with $17.1 MM Disease Team Research Award; the award is called to support preclinical development and Phase I/II clinical studies of novel cell therapy drug candidate to cure Retinitis Pigmentosa, a severe form of retina-degenerative blindness.
UCI, Gavin Herbert Eye Institute. Gavin Herbert Eye Institute at School of Medicine of University of California Irvine is faculty of internationally recognized physicians, surgeons and scientists that provide highly specialized training to future ophthalmologists, access to leading-edge clinical trials as well as sight-saving treatments and therapies for virtually any eye disorder. Eye surgeons, stem cell researchers, geneticists, infectious disease specialists and engineers are working on technologies and treatments for retinitis pigmentosa, macular degeneration, diabetic retinopathy, glaucoma, corneal disease and cataracts as well as a vaccine to prevent eye and genital herpes infections. These efforts have vaulted UC Irvine School of Medicine into the top echelons of U.S. institutions receiving National Institutes of Health grants for vision research.